Molecular adsorbents recirculating system (MARS): artificial liver support device for acute liver failure
Parrella A, Hiller JE, Mundy L
Record ID 32007000643
English
Authors' recommendations:
In conclusion, the highest level of evidence indicates that treatment of liver failure patients with MARS® therapy may increase their survival compared to patients who receive standard medical care. Further data from a randomised controlled trial, with a large number of enrolled patients should be conducted with sufficient power (80%) to detect a statistically significant difference between the MARS® intervention and control groups. In addition, treatment with MARS® therapy appears to have a beneficial effect on surrogate physiological outcomes.It has to be noted that critically ill patients with liver failure have very few treatment options available to them.
Details
Project Status:
Completed
Year Published:
2005
URL for published report:
Not Available
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
Australia
MeSH Terms
- Liver, Artificial
- Liver Failure, Acute
- Sorption Detoxification
Keywords
- hepatic encephalopathy
- liver failure
- artificial liver
- serum albumin
Contact
Organisation Name:
Adelaide Health Technology Assessment
Contact Address:
School of Public Health, Mail Drop 545, University of Adelaide, Adelaide SA 5005, AUSTRALIA, Tel: +61 8 8313 4617
Contact Name:
ahta@adelaide.edu.au
Contact Email:
ahta@adelaide.edu.au
Copyright:
Adelaide Health Technology Assessment (AHTA)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.